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This study aimed to compare the usage of Western medicine and traditional Korean medicine for treating joint disorders in Korea.
Data of claims from all medical institutions with billing statements filed to HIRA from 2011 to 2014 for the four most frequent joint
disorders were used for the analysis. Data from a total of 1,100,018 patients who received medical services from 2011 to 2014 were
analyzed. Descriptive statistics are presented as type of care and hospital type. All statistical analyses were performed using IBM
SPSS for Windows version 21. Of the 1,100,018 patients with joint disorders, 456,642 (41.5%) were males and 643,376 (58.5%) were
females. Per diem costs of hospitalization in Western medicine clinics and traditional Korean medicine clinics were approximately
160,000KRW and 50,000KRW, respectively. Among costs associated with Western medicine, physiotherapy cost had the largest
proportion (28.78%). Among costs associated with traditional Korean medicine, procedural costs and treatment accounted for
more than 70%, followed by doctors’ fees (21.54%). There were distinct differences in patterns of medical care use and cost of joint
disorders at the national level in Korea. This study is expected to contribute to management decisions for musculoskeletal disease
involving joint disorders.
1. Introduction
Musculoskeletal diseases are one of the leading causes of disa-
bility worldwide. It is a major contributor to health burden
and health care costs [1]. Korea has a rapidly aging popula-
tion due to the decrease in birth rate and increase in life
expectancy. The percentage of the population aged 65 years
or older will increase from 10.3% in 2008 to 15.6% in 2020 and
38.2% in 2050 [2]. Previous studies have reported findings
on the prevalence of musculoskeletal disease [3, 4]. As the
Korean population continues to age, the economic burden of
musculoskeletal disease will continue to increase. The total
economic burden of treating musculoskeletal is about 8.1 bil-
lion dollars [2]. Musculoskeletal diseases are the most com-
mon health problems that require the use of traditional
Korean medicine [5], an integral part of prevailing practice
and belief systems throughout Korea’s history. Starting from
the late 19th century, Western medical practices were intro-
duced by Christian missionaries to Korea. These practices
quickly supplanted traditional Korean medicine in institu-
tional health care. After the Korean War, the government
revived interest in traditional Korean medicine and estab-
lished colleges that specialize in that field, in addition to
colleges of Western medicine [6]. With this historical back-
ground, the Koreanmedical system is characterized by a dual
[7, 8], mutually exclusive medical system consisting of West-
ern medicine and traditional Korean medicine practices [9].
In Korea, primary care physicians workmostly in solo private
practices and are reimbursed on a fee-for-service basis. This
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system enables patients to choose and retain individual physi-
cians regardless of changes in employment status. There-
fore, Koreans can use both Western and traditional Korean
medicine to treat musculoskeletal disorders. Previous studies
have assessed the prevalence and cost of Korean medicine
[5, 6, 10–13]. However, most of these studies did not focus on
joint disorders [11, 14–16]. Particularly, the statuses of health
care utilization associated with joint disorders including
the scale of the whole population and health care costs of
patients receiving treatment for joint disorders are currently
unknown.Therefore, the objective of this studywas to analyze
claim data submitted to the Korean National Health Insur-
ance (NHI) and assessed by the Health Insurance Review
and Assessment Service (HIRA) to compare medical care use
betweenWestern medicine and traditional Korean medicine.
The results of this study will provide basic information for
future management decisions for musculoskeletal diseases
especially joint disorders in Korea.
2. Materials and Methods
2.1. Data Source. This study used claims data from the
2011–2014 National Patient Sample (NPS) dataset of HIRA.
Datasets generated and/or analyzed for this study period
are available from the HIRA-NPS repository [17]. The NPS
includes 3% sample data of 2011–2014 national insurance
billing data. It can represent the country as a whole (46 mil-
lion patients). The total number of filed claims and total
health expenditure have increased steadily. As of 2011, the
total number of filed claims has reached 1.3 billion,with a total
health expenditure of ∼51.5 trillion KRW. Patients were strat-
ified according to sex and age in 5-year intervals.TheseHIRA
claim data are compiled by health care providers nationwide.
They correspond to the number of claims submitted by
patients. Claims from patients with the Medicaid program,
government expenditures, and veteran patients are also
included in these claim data [18]. All data were deidentified
to ensure patient confidentiality. The HIRA Research Ethics
Committee of South Korea approved the study protocol.
2.2. Study Population. After reviewing frequent diseases each
year in traditional Korean medicine as described previously
[19], patients with the following four most frequent joint
disorders were included in this study: M17 (gonarthrosis
[arthrosis of knee]), M75 (shoulder lesions), S63 (dislocation,
sprain, and strain of joints and ligaments at wrist and hand
level), and S93 (dislocation, sprain, and strain of joints and
ligaments at ankle and foot level). Although dorsalgia (M54)
was at the top of the list, it was excluded from analysis since
there was no change in ranking by year. To observe changes
in the ranking of diseases by year, the remaining joints were
included in the study. We focused on musculoskeletal disor-
ders and injuries of the extremities.Thediagnoseswere coded
using the 6th revision of the Korean Classification of Diseases
(KCD-6) adapted from the International Classification of
Diseases, 10th revision. Data from the billing statements for
patients with missing cost data and those with zero total
cost were excluded. Patient might have visited more than
once during the study period (i.e., more than one claim per
patient). Therefore, the number of claims in this study was
higher than the total number of patients. A total of 7,996,903
claims for 1,100,018 patients with joint diseases with prefix
codes of M17, M75, S63, and S93 in primary diagnoses were
included for analysis through discussion of a panel of three
clinicians (one public health specialist, one Korean medical
doctor, and one statistician). A total of 1,100,018 patients were
finally included in our analysis (Figure 1).
2.3. Episode Creating Process. Claims data provided by HIRA
included raw data of treatment prescriptions for all patients
who received medical services over the course of one year
after removing personal and corporate information. Because
the claims were submitted monthly, charges in the statement
reflected up to one month of information. In other words,
patients who had been hospitalized for more than onemonth
would have been charged separately for each month. In such
cases, errors such as overestimation of the number of inpa-
tients and underestimation of medical expenses might occur
when performing statistical analyses. Therefore, episodes,
involving collecting and calibrating several claims charged
monthly for one consecutive medical practice were used. In
this study, separated claim forms of hospitalized patients were
bundled into one hospitalization episode. Variables used in
the episode creating process included claims identification
key, patient identification key, insurance type, main diagnosis
code, treatment type, treatment start date, and treatment end
date.
2.4. Main Descriptive Variables. The main descriptive vari-
ables were frequency and cost of medical care without
addressing a specific hypothesis. Frequency included the
number of hospitalizations and outpatient visits in Western
medicine and traditional Korean medicine clinics, interven-
tion (surgical and nonsurgical), and annual usage. Rehabilita-
tion-related nonsurgical interventions were classified accord-
ing to National Evidence-based Healthcare Collaborating
Agency reports [20].
Cost included average cost per patient and cost per day
(per diem) for joint disorders. Medical costs determined to
be eligible for reimbursement by HIRA out of treatment costs
were indicated in the submitted insurance claim statement.
Medical costs, that is, the sum of benefits reimbursed by
the insurer (Korean National Health Insurance Service) to
the medical care institutions, were classified as INSUP and
self-payment costs paid by the beneficiary (patient) as SLF.
It was expressed as total treatment cost in Korean Won
(1,000,000KRW). Each patient’s medical costs were calcu-
lated as the sum of costs listed on their claims. The average
treatment amount was the amount of total medical expenses
for one year divided by the number of patients. Per diem was
the amount of total medical expenses for one year divided
by the number of days of hospitalization or in an outpatient
clinic.
The number of reimbursed days included the number
of hospitalized days or outpatient visits and in-care drug
prescription days. These days were defined based on the
number of visits (for outpatient departments) or the length of
hospital stay (for inpatient departments) of patients indicated
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Number of T20 claims with joint ICD codes
M17, M75, S63, S93 in the NHP 2011–2014
(i) 2011: 1,885,740
(ii) 2012: 1,999,160
(iii) 2013: 2,052,435
(iv) 2014: 2,081,344
Excluded claims unmatched between
T20 and T30, T40, T53
(i) 2011: 2,480
(ii) 2012: 3,314
(iii) 2013: 2,327
(iv) 2014: 2,342
Number of T20 claims in the NHP 2011–2014
(i) 2011: 1,883,260
(ii) 2012: 1,995,846
(iii) 2013: 2,050,108
(iv) 2014: 2,079,002
Number of T20 claims in the NHP 2011–2014
(i) 2011: 1,877,877
(ii) 2012: 1,994,028
(iii) 2013: 2,048,720
(iv) 2014: 2,076,278
Excluded claims with missing cost or
0 total cost
(i) 2011: 5,373
(ii) 2012: 1,818
(iii) 2013: 1,388
(iv) 2014: 2,724
Patients included for analysis in T20 claims
(i) 2011: 268,048
(ii) 2012: 273,752
(iii) 2013: 278,170
(iv) 2014: 280,048
Total: 1,100,018 patients
Excluded claims of which main
disease is not M17 and M75, S63, S93
Aggregated claims connected within a
patient, a main disease, a medical type,
a medical institution, an insurance
type among hospitalization cases
Number of T20 claims in the NHP 2011–2014
(i) 2011: 1,481,325
(ii) 2012: 1,559,336
(iii) 2013: 1,594,147
(iv) 2014: 1,599,926
Figure 1: Flowchart of the study sample.
in the submitted insurance claim statement [14]. Days per
episode were calculated as total reimbursed days divided by
the total number of episodes. Patient andmedical institution-
related characteristics are defined as follows.
2.5. Patient Characteristics. Patient characteristics included
gender, age, medical insurance type, severity of disease,
existence of surgery, and type of medicine. The main attend-
ing hospital characteristics included hospital type, region,
ownership, the number of beds, the number of Western
doctors, and the number of traditional medical practitioners.
Patient demographic data obtained from the NHI claims
database included gender, age, and medical insurance type
(NHI,Medicaid, and others) at the date of visit of a health care
institution and the most frequently visited ones. Individuals
were qualified forMedicaid if they had a household income of
less than $600 per month. Medical services for veterans and
beneficiaries were free of charge as government expenditure.
Severity was measured using the Charlson Comorbidity
Index (CCI) [21] defined as the sum of weights related to each
condition for which a patient had available claim data. The
CCI score was determined based on the presence of specific
ICD-10 codes during one year [22]. In this study, CCI at
initiation was used as the CCI score of each patient.
2.6. Medical Institution Characteristics. The types of medical
practice were divided into three as follows: traditional,
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Western, and both traditional and Western. Hospital was
the main attending medical institution which was visited
most frequently by the patient for care. If visit frequency
per institution was the same, the main attending hospital
was the last health care institution that the patient visited.
Medical institutions included Tertiary andGeneral Hospitals,
hospitals, long-term care hospitals, Western Clinics, Dental
Hospitals and Clinics, Public Health Hospitals (admission
facility-equipped health center), Public Health Centers, Local
Public Health Clinics, Traditional Hospitals, and Traditional
Clinics. Region and ownership were the characteristics of the
medical institution that the patient visited.
2.7. Statistical Analysis. Basic characteristics of the study
sample are presented as frequencies and percentages. They
are presented for each operational definition. Descriptive
statistics are presented as type of care and hospital type. All
statistical analyses were performed using SPSS version 21 for
Windows (IBM Corp., Armonk, NY, USA).
3. Results
The general characteristics of the study population are sum-
marized in Table 1.
A total of 1,100,018 patients were included, including
456,642 (41.5%) males and 643,376 (58.5%) females. All four
years (from 2011 to 2014) showed higher percentages of
females than males. Patients under 29 years of age accounted
for the largest proportion (23.3%), followed by patients in
their 50s (20.5%) and 60s (16.8%). A total of 1,050,691 (95.5%)
patients were enrolled in the NHI scheme while the remain-
ing 49,012 patients (4.5%) were enrolled inMedicaid. Patients
with knee arthrodesis accounted for the most (24.2%), fol-
lowed by those with foot joint disease.More than half (52.5%)
of these patients had knee arthropathy. Approximately 70%
(70.5%) of patients had mild joint disorder with CCI score
of 0. Among the 1,100,018 patients, 18,041 (1.6%) patients
underwent surgery while the majority (98.4%) of patients
underwent nonsurgical procedures. For body regions where
basic physical therapy was performed more than three times,
the knee and shoulder regions accounted for more than
25%. For regions that needed surgery, the knees accounted
for the most. For regions that underwent acupuncture two
times or more, the shoulder, hand, and foot areas accounted
for 30% or more (Table 2). Regardless of disease type, only
1.6% of patients underwent surgery, of which knee surgery
was the most frequently performed type (43%∼44%). The
results of nonsurgical intervention distribution are shown
in Table 3. The main attending medical institutions included
58,245 (5.3%) Tertiary andGeneral Hospitals, 118,408 (10.8%)
hospitals, 8,638 (0.8%)Western Clinics, 592,155 (53.8%) long-
term care hospitals, 6,473 (29.6%) Traditional Hospitals,
and (28.7%) Traditional Clinics. However, the results were
different for hospitalization and outpatient visits (Table 4).
Hospitalization was mainly in the order of hospitals > long-
term care hospital >Western Clinic.This is mainly due to the
characteristics of patients who require surgery. On the other
hand, among the same primary clinic institutions, Traditional
Clinics showed a higher proportion than Western Clinic for
outpatients. The admission rates were 96.90% in Western
medicine clinic and 3.10% in traditional Korean medicine
clinics. Among all outpatient visits, 67.85% involved orthodox
medicine while 32.15% involved traditional Koreanmedicine.
In Western medicine clinics, patients were hospitalized most
frequently in hospitals, followed by long-term care hospitals.
Hospitalization at hospital level gradually decreased from
37.17% in 2011 to 36.37% in 2014. On the other hand, the
percentage of patients whowere hospitalizedmainly in Tradi-
tionalHospitals increased from2.12% in 2011 to 3.28% in 2014.
Outpatient visits accounted formost visits to hospitals (West-
ernmedicine: 56.26%; Traditional Koreanmedicine: 31.69%).
While the percentage of outpatients at Western medicine
clinics steadily increased from 66.19% in 2011 to 68.93%
by 2014, the percentage of outpatients at traditional Korean
medicine clinics steadily decreased from 33.81% in 2011 to
31.07% in 2014. Most (91.0%) institutions were privately
owned, andmost (80.4%) of themwere located outside Seoul.
The majority (95.2%) of institutions had fewer than 5 beds.
There was no significant difference among the four groups
according to year. The total average treatment cost (RPE) is
the sum of INSUP and SLF paid to medical care institution.
RPE per patient was 185,933 KRW in 2011, 192,290KRW
in 2012, 202,967KRW in 2013, and 208,739KRW in 2014.
Women incurred more medical expenses in 2011 to 2014
compared to men. Expenditure was increased with age.
It peaked in patients in their 70s with a minimum of
377,448KRW to a maximum of 388,445KRW. In terms of
expense by the type of joint lesion, knee lesions (M17) had
the highest expense among the four types of joint disorders,
followed by shoulder lesions (M75). As the severity of lesion
was increased, the expense was also increased. However,
the difference in expense was not statistically insignificant.
Patients who were hospitalized spent 20 times more than
those who were not hospitalized. The average treatment
costs per patient in inpatient care and outpatient care were
192,414 and 65,319 KRW, respectively. Patients who used only
traditional Korean medicine spent twice less than those
who only used Western medicine. The range of RPE for
Western medicine was from 181,225 KRW to 198,661 KRW.
The range of RPE for traditional Korean medicine was from
82,019 KRW to 96,325KRW. There were no differences in
costs over 400,000KRW among hospitals that practiced
Western medicine (Tertiary and General Hospital, hospital,
and Western Clinic). Costs for Western medicine hospitals
were the highest, followed by that for Traditional Hospitals
and long-term care hospitals (Table 5).
The frequency and total medical expenditures for West-
ern medicine and traditional Korean medicine are shown
in Table 6. There were 21,894,252 claims with a cost of
168,024,474 (1000KRW) for Western medicine. However,
there were only 9,628,946 claims with a cost of 38,602,696
(1000KRW) for traditional Korean medicine. The medical
expense per visit in an outpatient clinic was 22,000KRW
for Western medicine and about 18,000KRW for traditional
Korean medicine. The day per episode of traditional Korean
medicine was longer than that of Western medicine. After
analyzing the medical cost of claims for Western medicine
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Table 3: Comparison of rate of surgery by diagnostic code.
Year Total Knee lesions [M17]
Shoulder lesions
[M75]
Wrist and hand
level [S63]
Ankle and foot
level [S93]
𝑁∗ % 𝑁 % 𝑁 % 𝑁 % 𝑁 %
Total Unit 1,481,969 100.00 648,757 43.78 447,224 30.18 136,972 9.24 249,016 16.80
2011
No 𝑁 1,477,896 646,826 445,926 136,436 248,708
% (99.73) (99.70) (99.71) (99.61) (99.88)
Yes 𝑁 4,073 1,931 1,298 536 308
% (.27) (.30) (.29) (.39) (.12)
Total Unit 1,560,032 100.00 683,247 43.80 471,040 30.19 144,044 9.23 261,701 16.78
2012
No 𝑁 1,555,319 681,193 469,334 143,450 261,342
% (99.70) (99.70) (99.64) (99.59) (99.86)
Yes 𝑁 4,713 2,054 1,706 594 359
% (.30) (.30) (.36) (.41) (.14)
Total Unit 1,594,949 100.00 698,540 43.80 475,765 29.83 150,621 9.44 270,023 16.93
2013
No 𝑁 1,589,924 696,372 473,895 150,072 269,585
% (99.68) (99.69) (99.61) (99.64) (99.84)
Yes 𝑁 5,025 2,168 1,870 549 438
% (.32) (.31) (.39) (.36) (.16)
Total Unit 1,600,774 100.00 706,617 44.14 468,443 29.26 152,359 9.52 273,355 17.08
2014
No 𝑁 1,595,458 704,410 466,431 151,772 272,845
% (99.67) (99.69) (99.57) (99.61) (99.81)
Yes 𝑁 5,316 2,207 2,012 587 510
% (.33) (.31) (.43) (.39) (.19)
∗A patient could be hospitalized more than once during the study period, which resulted in more than one claim per patient. Thus, the number of claims in
the study was higher than the number of patients.
and traditional Korean medicine, the proportion of each
item was different. For Western medicine, the proportion
of psychiatric costs was the highest (28.78%), followed by
doctors’ fees (27.7%), injections (16.59%), radiotherapy costs
(8.74%), and laboratory costs (7.09%). For traditional Korean
medicine, the proportion of doctors’ fees was the highest
(26.48%), followed by procedural costs (25.16%), injections
(13.52%), admission costs (9.23%), and psychiatric costs
(7.26%). Regarding traditional Korean medicine, most (70%)
medical treatment costs were procedural costs and treatment
costs.Doctors’ fees accounted for only 21.54%of the total cost,
similar to doctors’ fees for Western medicine. Procedural
costs accounted for the most (56.45%) among total cost for
Western medicine. The second largest proportion was doc-
tors’ fees (40.49%). Admission costs, medication costs, and
laboratory costs comprised less than 1% (Table 7).
In Table 8, it was not possible to use the inspection and
image capturing system of 0 only in the Traditional Clinic
because of legal restrictions. According to the region of
disease, the knee accounted for the most, followed by the
shoulder, foot, and hand in terms of hospitalization and out-
patient visits. As the years progressed, the number of inpa-
tient and outpatient visits was also increased for all body
regions. Among the hospitalized patients, the number of
claims for all years after 2011 increased the most for shoulder
joints (78.43%) compared to 2011, followed by knees (61.93%),
foot (50.72%), and hands (16.29%). On the other hand,
outpatient cases occurred in the following order based on
the location of the disease: hand (11.24%) > knee (8.49%) >
ankle (9.63%) > shoulder (4.35%). According to time (year),
difference in current usage patterns was especially different
between Western medicine and traditional Korean medi-
cine. Particularly, hospitalization increases for the knee and
shoulder areas (shoulder: 105.00%, knee: 250.00%) in tradi-
tional Korean medicine were higher than those in Western
medicine (shoulder: 77.99%, knee: 58.04%). The proportion
of outpatient visits for the hand region in traditional Korean
medicine increased steadily (2012: 4.31%, 2013: 14.49%, 2014:
13.46%). However, the shoulder area showed steady decrease
(2011: −8.31%, 2012: −9.73%, 2014: −16.45%) (Table 9).
The costs and length of hospitalization by year are shown
in Tables 10–17. Basic physical therapy was the most com-
mon nonsurgical intervention in Western medicine while
acupuncture was themost common nonsurgical intervention
in traditional Korean medicine. Both procedures are steady
treatments that require two or more treatments. The propor-
tions of acupuncture and basic physical therapy are almost
equal (Table 18).
4. Discussion
This study assessed the prevalence and costs of most fre-
quently used treatments for joint disorders in Korea to
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Table 6: Comparison of medical costs by type of medicine in 2011–2014.
Unit Year Type of medicine Frequency Insurance charge LOS
𝑁∗ % Cost† % Per diem‡ Days per episode§
H
2011
WM 8,499 97.75 16,542 99.37 162,276 10.98
TM 196 2.25 105 0.63 53,097 12.23
Total 8,695 100 16,647 100 159,815 11.01
2012
WM 10,560 97.05 18,063 99.03 157,605 9.67
TM 321 2.95 178 0.97 57,256 12.18
Total 10,881 100 18,240 100 154,644 9.75
2013
WM 12,152 96.79 19,969 98.65 155,222 9.31
TM 403 3.21 216 1.35 62,217 10.78
Total 12,555 100 20,185 100 152,237 9.35
2014
WM 13,759 96.35 20,077 98.65 154,829 8.51
TM 521 3.65 276 1.35 60,435 10.72
Total 14,280 100 20,353 100 151,385 8.59
O
2011
WM 974,537 66.19 23,827 71.81 22,030 1.2
TM 497,877 33.81 9,354 28.19 18,573 1.04
Total 1,472,414 100 33,181 100 20,861 1.15
2012
WM 1,054,900 68.13 24,848 72.24 23,555 1.12
TM 493,535 31.87 9,551 27.76 19,352 1.03
Total 1,548,435 100 34,399 100 22,215 1.09
2013
WM 1,075,935 68.03 26,203 72.24 24,354 1.11
TM 505,652 31.97 10,071 27.76 19,917 1.03
Total 1,581,587 100 36,274 100 22,935 1.08
2014
WM 1,092,995 68.93 27,887 73.19 25,514 1.1
TM 492,651 31.07 10,218 26.81 20,740 1.03
Total 1,585,646 100 38,104 100 24,031 1.08
∗A patient could be hospitalized more than once during the study period, which resulted in more than one claim per patient. Thus, the number of claims in
the study was higher than the number of patients. †Costs determined to be eligible for reimbursement by the HIRA (Health Insurance Review and Assessment
Service) out of the total treatment amount were indicated in the submitted insurance claim statement. Costs are expressed in Korean Won (1,000,000KRW).
‡Per diem is the average daily cost of services covered by National Health Insurance. It is expressed in Korean Won. §Days per episode are the total number
of reimbursed days divided by the total number of episodes. The number of reimbursed days includes the number of hospitalized days or outpatient visits and
in-care drug prescription days. H, hospitalization; O, outpatient; WM, Western medicine; TM, Korean traditional medicine.
provide basic information for future usual care guidelines
that may reduce health expenditures and help solve National
Health Insurance deficits. This study used the 2011–2014
HIRA-NPS data consisting of 3% age-stratified and gender-
stratified random samples. It appropriately reflected the
South Korean population of 2011–2014 to capture real-world
medical use and cost in joint disorders.
The results of the study showed that the proportion
of female patients was higher compared to that of male
patients. This is consistent with previous findings showing
that women are more likely to utilize health care than
men [23, 24]. This might be due to gender role differ-
ences such as occupation, hours of work, and occupa-
tional activities including housework and biological fac-
tors. Women are typically responsible for childcare and
housework while men are typically expected to have a job
[25].
The shoulder and knee joints accounted for themost hos-
pital visits and increased steeply. In Korea, musculoskeletal
disease accounted for 28.2% of National Health Insurance
Corporation (NHIC) inpatient and outpatient claims. Knee
joint disease has been ranked the 6th among reasons for
inpatient care visit and the 5th among reasons for outpatient
care visit among the population aged 65 years or older [26].
The incidence of gonarthrosis has been steadily increasing in
Korea. Its rate in women was much higher than that in men
[27].
While Western Clinics were the most frequently visited
medical institution type between 2011 and 2014, the finding
that Traditional Clinics were the next most frequently visited
in this study was noteworthy. The Korean medical system is
characterized by both Western and traditional Korean med-
ical practices. In 2014, the number of claims from Western
medicine was 49,031 for Tertiary and General Hospitals and
16,935 for hospitals and clinics. On the contrary, the number
of claims from traditional Korean medicine was 14,729 for
hospitals and 7,690 for clinics [26]. These circumstances
reflect the high proportion of traditional Korean medicine
use for joint disorders [9]. Our results are consistent with
previous results showing that Traditional Clinics are the
second most visited institution by patients with nonspecific
low back pain [14].
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Table 10: Numbers of hospitalizations for gonarthrosis [M17] patients by hospital type.
Year Type ofmedicine Hospital type
Frequency Hospitalization costs LOS
𝑁∗ % Cost† % Per diem‡ Days perepisode§
2011
Western
Tertiary Hospital 204 3.98 1,225 9.50 460,420 14.20
General Hospital 589 11.49 3,215 24.93 254,225 22.53
Hospital 1,689 32.94 7,044 54.62 225,222 17.68
Long-term care hospital 1,857 36.21 553 4.29 94,819 4.42
Western Clinic 683 13.32 794 6.16 81,749 13.64
Public Health Hospital 2 0.04 1 0.01 39,420 11.00
Total 5,024 97.97 12,832 99.50 170,393 12.66
Traditional
Traditional Hospital 99 1.93 62 0.48 57,349 13.10
Traditional Clinic 5 0.10 2 0.02 33,235 13.80
Total 104 2.03 64 0.50 56,190 13.13
Total 5,128 100.00 12,896 100.00 168,077 12.67
2012
Western
Tertiary Hospital 187 2.86 1,190 8.81 490,276 14.06
General Hospital 615 9.42 3,188 23.60 236,169 22.07
Hospital 2,011 30.80 7,435 55.05 212,520 15.80
Long-term care hospital 2,792 42.76 700 5.18 99,643 3.50
Western Clinic 710 10.87 868 6.42 78,343 13.69
Public Health Hospital 1 0.02 1 0.01 42,477 19.00
Total 6,316 96.74 13,383 99.08 158,039 10.69
Traditional
Traditional Hospital 190 2.91 114 0.84 62,827 12.07
Traditional Clinic 23 0.35 11 0.08 33,646 15.57
Total 213 3.26 125 0.92 59,676 12.45
Total 6,529 100.00 13,507 100.00 154,830 10.74
2013
Western
Tertiary Hospital 195 2.65 1,287 8.79 454,263 16.49
General Hospital 725 9.87 3,681 25.16 234,228 21.27
Hospital 1,997 27.18 7,678 52.49 215,432 16.46
Long-term care hospital 3,393 46.18 888 6.07 98,884 3.62
Western Clinic 774 10.53 939 6.42 84,784 12.97
Public Health Hospital 2 0.03 1 0.01 44,311 16.00
Total 7,086 96.45 14,474 98.95 153,802 10.42
Traditional
Traditional Hospital 234 3.18 140 0.96 64,218 11.45
Traditional Clinic 27 0.37 14 0.10 42,487 13.56
Total 261 3.55 154 1.05 61,970 11.67
Total 7,347 100.00 14,628 100.00 150,539 10.47
2014
Western
Tertiary Hospital 272 3.28 1,641 11.46 459,732 14.81
General Hospital 727 8.75 3,723 26.01 233,047 22.00
Hospital 2,152 25.92 6,911 48.29 205,374 14.52
Long-term care hospital 4,022 48.43 1,045 7.30 102,035 3.44
Western Clinic 766 9.22 783 5.47 75,945 13.00
Public Health Hospital 1 0.01 0 0.00 63,640 4.00
Total 7,940 95.62 14,103 98.54 151,771 9.46
Traditional
Traditional Hospital 329 3.96 193 1.35 64,804 11.00
Traditional Clinic 35 0.42 16 0.11 38,910 13.77
Total 364 4.38 209 1.46 62,314 11.26
Total 8,304 100.00 14,312 100.00 147,849 9.54
∗Patients with overlapping records were tallied as one patient (overlap was not allowed). †Costs determined to be eligible for reimbursement by the HIRA
(Health Insurance Review and Assessment Service) out of the total treatment amount were indicated in the submitted insurance claim statement. They are
expressed as means and are in Korean Won (1,000,000KRW). ‡Per diem is the average daily cost of services covered by National Health Insurance. §Days per
episode are the total number of hospitalized days divided by the total number of hospitalizations.
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Table 11: Number of outpatients with gonarthrosis [M17] by hospital type.
Year Type ofmedicine Hospital type
Frequency Outpatient costs LOS
𝑁
∗ % Cost† % Per diem‡ Days perepisode§
2011
Western
Tertiary Hospital 3,771 0.59 199 1.35 39,490 1.76
General Hospital 13,999 2.18 689 4.69 32,279 6.26
Hospital 28,259 4.39 1,667 11.33 28,169 2.04
Long-term care hospital 1,872 0.29 95 0.65 15,504 3.51
Clinic 458,027 71.23 9,641 65.55 21,049 1.02
Public Health Center 1,495 0.23 5 0.04 3,474 1.00
Local Public Health Clinic 389 0.06 5 0.03 12,991 7.70
Public Health Hospital 1,018 0.16 27 0.18 26,723 1.67
Total 508,830 79.13 12,329 83.83 21,823 1.24
Traditional
Traditional Hospital 1,022 0.16 49 0.33 16,099 2.81
Traditional Clinic 133,159 20.71 2,330 15.84 17,497 1.04
Total 134,181 20.87 2,379 16.17 17,486 1.05
Total 643,011 100.00 14,707 100.00 20,918 1.20
2012
Western
Tertiary Hospital 4,817 0.71 215 1.42 44,547 1.55
General Hospital 20,949 3.10 720 4.76 34,367 4.58
Hospital 54,982 8.13 1,858 12.27 33,789 1.12
Long-term care hospital 4,519 0.67 99 0.66 22,003 1.42
Clinic 448,226 66.29 9,691 64.01 21,621 1.02
Public Health Center 1,592 0.00 6 0.00 3,811 1.01
Local Public Health Clinic 439 0.24 3 0.04 7,361 4.12
Public Health Hospital 855 0.06 26 0.02 30,431 1.46
Dental Hospital 2 0.13 0 0.17 24,970 1.00
Total 536,381 79.33 12,618 83.34 23,525 1.18
Traditional
Traditional Hospital 2,332 0.34 50 0.33 21,369 1.16
Traditional Clinic 137,458 20.33 2,472 16.33 17,986 1.03
Total 139,790 20.67 2,522 16.66 18,042 1.03
Total 676,171 100.00 15,140 100.00 22,391 1.15
2013
Western
Tertiary Hospital 4,949 0.72 218 1.37 44,048 1.57
General Hospital 21,512 3.12 783 4.92 36,416 4.20
Hospital 55,199 7.99 1,879 11.81 34,034 1.12
Long-term care hospital 4,780 0.69 104 0.66 21,854 1.49
Clinic 456,160 66.06 10,203 64.13 22,367 1.01
Public Health Center 1,678 0.24 6 0.04 3,442 1.05
Local Public Health Clinic 191 0.03 2 0.02 12,633 6.90
Public Health Hospital 692 0.10 23 0.15 33,579 1.97
Total 545,161 78.94 13,219 83.09 24,248 1.16
Traditional
Traditional Hospital 2,306 0.33 52 0.32 22,375 1.13
Traditional Clinic 143,105 20.72 2,639 16.59 18,443 1.03
Total 145,411 21.06 2,691 16.91 18,505 1.03
Total 690,572 100.00 15,910 100.00 23,039 1.14
2014
Western
Tertiary Hospital 5,377 0.77 243 1.43 45,133 1.24
General Hospital 22,999 3.30 856 5.06 37,234 3.85
Hospital 57,441 8.23 1,986 11.74 34,571 1.11
Long-term care hospital 4,748 0.68 106 0.63 22,320 1.48
Clinic 461,684 66.18 10,962 64.81 23,742 1.01
Public Health Center 2,372 0.00 8 0.00 3,298 1.00
Local Public Health Clinic 171 0.34 2 0.05 12,230 6.67
Public Health Hospital 732 0.02 21 0.01 28,470 1.31
Dental Hospital 11 0.10 0 0.12 18,469 1.00
Total 555,535 79.63 14,183 83.86 25,531 1.15
Traditional
Traditional Hospital 2,516 0.36 59 0.35 23,541 1.13
Traditional Clinic 139,576 20.01 2,670 15.79 19,127 1.03
Total 142,092 20.37 2,729 16.14 19,205 1.03
Total 697,627 100.00 16,912 100.00 24,242 1.12
∗Patients with overlapping records were tallied as one patient (overlap was not allowed). †Costs determined to be eligible for reimbursement by the HIRA
(Health Insurance Review and Assessment Service) out of the total treatment amount were indicated in the submitted insurance claim statement. They is
expressed as a mean and are in KoreanWon (1,000,000KRW). ‡Per diem is the average daily cost of services covered by National Health Insurance. §Days per
episode are the total number of outpatient visit days including drug prescription days divided by the total number of outpatient visits.
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Table 12: Number of hospitalizations for shoulder lesion [M75] patients by hospital type.
Year Type ofmedicine Hospital type
Frequency Hospitalization costs LOS
𝑁∗ % Cost† % Per diem‡ Days perepisode§
2011
Western
Tertiary Hospital 135 5.54 278 9.55 377,378 6.08
General Hospital 381 15.62 765 26.31 210,523 12.83
Hospital 1,101 45.14 1,608 55.27 203,071 8.86
Long-term care hospital 589 24.15 69 2.37 94,749 1.45
Western Clinic 193 7.91 167 5.74 99,580 11.10
Total 2,399 98.36 2,886 99.24 179,142 7.69
Traditional
Traditional Hospital 39 1.6 22 0.75 53203 14.26
Traditional Clinic 1 0.04 0 0.01 21440 14
Total 40 1.64 22 0.76 52409 14.25
Total 2,439 100.00 2,908 100.00 177,064 7.80
2012
Western
Tertiary Hospital 142 4.53 318 8.32 374,833 6.37
General Hospital 468 14.92 989 25.85 208,846 12.43
Hospital 1,547 49.33 2,168 56.66 200,108 8.36
Long-term care hospital 661 21.08 75 1.96 98,519 1.25
Western Clinic 252 8.04 242 6.33 138,525 9.81
Total 3,070 97.90 3,792 99.13 182,594 7.48
Traditional
Traditional Hospital 62 1.98 32 0.84 58,945 11.53
Traditional Clinic 4 0.13 1 0.03 31,056 14.25
Total 66 2.10 33 0.87 57,255 11.70
Total 3,136 100.00 3,826 100.00 179,956 7.57
2013
Western
Tertiary Hospital 169 4.50 388 8.65 379,396 6.41
General Hospital 582 15.48 1,212 27.01 188,152 13.07
Hospital 1,920 51.08 2,524 56.27 193,851 7.58
Long-term care hospital 739 19.66 100 2.22 95,331 1.68
Western Clinic 274 7.29 223 4.97 156,193 8.29
Public Health Hospital 1 0.03 0 0.00 89,370 1.00
Total 3,685 98.03 4,446 99.12 178,875 7.26
Traditional
Traditional Hospital 68 1.81 37 0.82 64,497 10.57
Traditional Clinic 6 0.16 3 0.06 40,844 14.17
Total 74 1.97 40 0.88 62,579 10.86
Total 3,759 100.00 4,485 100.00 176,585 7.33
2014
Western
Tertiary Hospital 161 3.70 333 6.97 377,875 5.68
General Hospital 671 15.42 1,214 25.45 202,746 10.41
Hospital 2,298 52.80 2,773 58.12 188,633 6.86
Long-term care hospital 817 18.77 134 2.80 99,291 2.07
Western Clinic 323 7.42 276 5.79 164,902 8.50
Total 4,270 98.12 4,730 99.12 179,097 6.58
Traditional
Traditional Hospital 76 1.75 39 0.83 60,405 10.09
Traditional Clinic 6 0.14 2 0.05 23,633 17.17
Total 82 1.88 42 0.88 57,714 10.61
Total 4,352 100.00 4,772 100.00 176,810 6.66
∗Patients with overlapping records were tallied as one patient (overlap not allowed). †Costs determined to be eligible for reimbursement by the HIRA (Health
Insurance Review and Assessment Service) out of the total treatment amount were indicated in the submitted insurance claim statement. They are expressed
as means and are in Korean Won (1,000,000KRW). ‡Per diem is the average daily cost of services covered by National Health Insurance. §Days per episode
are the total number of hospitalized days divided by the total number of hospitalizations.
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Table 13: Number of outpatients with shoulder lesions [M75] by hospital type.
Year Type ofmedicine Hospital type
Frequency Outpatient costs LOS
𝑁
∗ % Cost† % Per diem‡ Days perepisode§
2011
Western
Tertiary Hospital 3,279 0.74 147 1.55 29,079 2.14
General Hospital 8,754 1.97 420 4.42 26,730 4.09
Hospital 16,434 3.70 803 8.45 21,712 2.21
Long-term care hospital 1,120 0.25 47 0.50 16,906 2.84
Clinic 228,892 51.48 4,559 47.99 19,916 1.01
Dental Hospital 8 0.00 0 0.00 18,765 1.63
Public Health Center 301 0.07 1 0.01 3,204 1.00
Local Public Health Clinic 22 0.00 0 0.00 5,281 1.91
Public Health Hospital 126 0.03 3 0.03 23,603 1.25
Total 258,936 58.24 5,980 62.96 20,345 1.21
Traditional
Traditional Hospital 1,327 0.30 62 0.66 17,637 2.58
Traditional Clinic 184,372 41.47 3,456 36.39 18,746 1.04
Total 185,699 41.76 3,519 37.04 18,738 1.05
Total 444,635 100.00 9,499 100.00 19,674 1.14
2012
Western
Tertiary Hospital 4,805 1.03 150 1.54 31,203 1.33
General Hospital 16,148 3.45 418 4.29 25,911 2.07
Hospital 42,956 9.18 1,004 10.29 23,362 1.05
Long-term care hospital 2,372 0.51 52 0.53 21,931 1.40
Clinic 230,518 49.28 4,790 49.14 20,780 1.01
Dental Hospital 5 0.00 0 0.00 26,800 1.00
Public Health Center 552 0.12 2 0.02 3,290 1.00
Local Public Health Clinic 12 0.00 0 0.00 9,058 3.92
Public Health Hospital 168 0.04 4 0.04 22,856 3.33
Total 297,536 63.60 6,420 65.85 21,577 1.08
Traditional
Traditional Hospital 2,348 0.50 52 0.53 22,053 1.31
Traditional Clinic 167,911 35.89 3,277 33.62 19,517 1.03
Total 170,259 36.40 3,329 34.15 19,552 1.04
Total 467,795 100.00 9,749 100.00 20,840 1.07
2013
Western
Tertiary Hospital 5,053 1.07 167 1.63 33,032 1.29
General Hospital 15,611 3.31 434 4.26 27,831 2.06
Hospital 46,514 9.86 1,108 10.85 23,823 1.05
Long-term care hospital 2,105 0.45 49 0.48 23,288 1.45
Clinic 234,099 49.61 5,077 49.73 21,688 1.01
Dental Hospital 6 0.00 0 0.00 17,590 1.00
Public Health Center 701 0.15 2 0.02 2,487 1.00
Local Public Health Clinic 24 0.01 0 0.00 6,914 2.96
Public Health Hospital 132 0.03 3 0.03 25,864 1.74
Total 304,245 64.47 6,841 67.01 22,486 1.08
Traditional
Traditional Hospital 2,163 0.46 51 0.50 23,727 1.09
Traditional Clinic 165,476 35.07 3,317 32.49 20,047 1.03
Total 167,639 35.53 3,369 32.99 20,095 1.03
Total 471,884 100.00 10,210 100.00 21,636 1.06
2014
Western
Tertiary Hospital 4,474 0.96 149 1.42 33,281 1.34
General Hospital 17,733 3.82 502 4.79 28,320 2.11
Hospital 48,171 10.38 1,136 10.85 23,590 1.04
Long-term care hospital 2,106 0.45 50 0.47 23,507 1.36
Clinic 232,309 50.07 5,315 50.74 22,881 1.01
Public Health Center 471 0.10 2 0.02 3,848 1.37
Local Public Health Clinic 35 0.01 0 0.00 7,430 3.80
Public Health Hospital 211 0.05 6 0.06 28,187 1.34
Total 305,510 65.84 7,160 68.35 23,437 1.09
Traditional
Traditional Hospital 3,330 33.44 73 30.96 21,781 1.03
Traditional Clinic 155,153 0.72 3,243 0.69 20,903 1.03
Total 158,483 34.16 3,316 31.65 20,921 1.03
Total 463,993 100.00 10,476 100.00 22,578 1.07
∗Patients with overlapping records were tallied as one patient (overlap was not allowed). †Costs determined to be eligible for reimbursement by the HIRA
(Health Insurance Review and Assessment Service) out of the total treatment amount were indicated in the submitted insurance claim statement. They are
expressed as means and are in Korean Won (1,000,000KRW). ‡Per diem is the average daily cost of services covered by National Health Insurance. §Days per
episode are the total number of outpatient visit days including drug prescription days divided by the total number of outpatient visits.
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Table 14: Number of hospitalizations for wrist and hand level lesions [S63] by hospital type.
Year Type ofmedicine Hospital type
Frequency Hospitalization costs LOS
𝑁∗ % Cost† % Per diem‡ Days perepisode§
2011
Western
Tertiary Hospital 11 4.98 13 7.68 278,227 5.45
General Hospital 45 20.36 43 25.65 179,511 6.20
Hospital 97 43.89 74 44.40 139,886 6.36
Long-term care hospital 11 4.98 1 0.84 61,642 2.18
Western Clinic 52 23.53 34 20.56 82,895 9.83
Total 216 97.74 165 99.13 137,482 6.90
Traditional
Traditional Hospital 4 1.81 1 0.59 50,891 4.75
Traditional Clinic 1 0.45 0 0.28 32,616 14.00
Total 5 2.26 1 0.87 47,236 6.60
Total 221 100.00 166 100.00 135,440 6.90
2012
Western
Tertiary Hospital 9 4.31 10 6.32 248,187 4.89
General Hospital 32 15.31 31 20.03 181,560 8.19
Hospital 112 53.59 87 55.96 127,213 7.51
Long-term care hospital 13 6.22 1 0.83 99,160 1.00
Western Clinic 38 18.18 25 15.80 91,169 9.32
Total 204 97.61 154 98.93 132,573 7.42
Traditional
Traditional Hospital 2 0.96 1 0.61 53,661 8.00
Traditional Clinic 3 1.44 1 0.46 41,900 7.33
Total 5 2.39 2 1.07 46,604 7.60
Total 209 100.00 156 100.00 130,517 7.43
2013
Western
Tertiary Hospital 11 4.12 13 7.25 342,630 3.73
General Hospital 50 18.73 47 26.27 156,802 6.76
Hospital 111 41.57 85 46.85 130,977 6.95
Long-term care hospital 44 16.48 4 1.98 80,871 1.09
Western Clinic 47 17.60 30 16.67 88,549 10.30
Total 263 98.50 179 99.03 128,774 6.40
Traditional Traditional Hospital 4 1.50 2 0.97 53,481 8.00
Total 4 1.50 2 0.97 53,481 8.00
Total 267 100.00 180 100.00 127,646 6.42
2014
Western
Tertiary Hospital 13 5.06 12 5.82 210,379 4.00
General Hospital 65 25.29 71 33.81 167,548 8.48
Hospital 118 45.91 97 46.30 137,949 6.69
Long-term care hospital 14 5.45 1 0.54 81,609 1.00
Western Clinic 43 16.73 27 12.62 88,134 8.91
Total 253 98.44 208 99.08 137,691 7.08
Traditional
Traditional Hospital 3 1.17 1 0.59 64,672 8.00
Traditional Clinic 1 0.39 1 0.33 36,168 19.00
Total 4 1.56 2 0.92 57,546 10.75
Total 257 100.00 210 100.00 136,444 7.13
∗Patients with overlapping records were tallied as one patient (overlap was not allowed). †Costs determined to be eligible for reimbursement by the HIRA
(Health Insurance Review and Assessment Service) out of the total treatment amount were indicated in the submitted insurance claim statement. They are
expressed as means and are in Korean Won (1,000,000KRW). ‡Per diem is the average daily cost of services covered by National Health Insurance. §Days per
episode are the total number of hospitalized days divided by the total number of hospitalizations.
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Table 15: Number of outpatients for wrist and hand level lesions [S63] by hospital type.
Year Type ofmedicine Hospital type
Frequency Outpatient costs LOS
𝑁
∗ % Cost† % Per diem‡ Days perepisode§
2011
Western
Tertiary Hospital 251 0.18 19 0.60 58,745 1.58
General Hospital 2,612 1.91 155 4.95 44,742 1.62
Hospital 7,082 5.18 319 10.18 29,974 1.58
Long-term care hospital 321 0.23 12 0.37 18,678 1.99
Clinic 73,276 53.59 1,618 51.67 22,082 1.00
Public Health Center 39 0.03 0 0.01 5,699 1.00
Local Public Health Clinic 13 0.01 0 0.01 18,520 11.46
Public Health Hospital 30 0.02 1 0.02 18,767 1.23
Total 83,624 61.16 2,124 67.81 23,546 1.08
Traditional
Traditional Hospital 545 0.40 21 0.68 18,048 2.18
Traditional Clinic 52,561 38.44 987 31.51 18,777 1.03
Total 53,106 38.84 1,008 32.19 18,770 1.04
Total 136,730 100.00 3,132 100.00 21,691 1.06
2012
Western
Tertiary Hospital 306 0.21 16 0.48 51,987 1.36
General Hospital 3,404 2.37 146 4.41 42,810 1.19
Hospital 11,477 7.98 357 10.80 31,071 1.04
Long-term care hospital 667 0.46 13 0.40 19,954 1.10
Clinic 72,525 50.42 1,680 50.86 23,163 1.01
Public Health Center 1 0.00 0 0.00 5,790 1.00
Local Public Health Clinic 13 0.01 0 0.00 8,726 4.00
Public Health Hospital 46 0.03 1 0.04 29,252 1.43
Total 88,439 61.49 2,213 66.99 25,022 1.02
Traditional
Traditional Hospital 838 0.58 18 0.53 20,947 1.05
Traditional Clinic 54,556 37.93 1,073 32.48 19,664 1.02
Total 55,394 38.51 1,090 33.01 19,683 1.02
Total 143,833 100.00 3,303 100.00 22,966 1.02
2013
Western
Tertiary Hospital 297 0.20 19 0.54 65,123 1.40
General Hospital 3,512 2.34 163 4.58 46,354 1.19
Hospital 10,971 7.30 360 10.13 32,801 1.07
Long-term care hospital 484 0.32 10 0.28 20,811 1.07
Clinic 74,188 49.34 1,758 49.50 23,690 1.00
Public Health Center 34 0.00 0 0.00 3,086 1.00
Local Public Health Clinic 7 0.02 0 0.00 7,674 3.00
Public Health Hospital 52 0.00 1 0.00 24,083 1.23
Dental Hospital 1 0.03 0 0.04 24,540 1.00
Total 89,546 59.56 2,311 65.09 25,808 1.02
Traditional
Traditional Hospital 956 0.64 22 0.62 22,855 1.05
Traditional Clinic 59,845 39.80 1,218 34.30 20,350 1.02
Total 60,801 40.44 1,240 34.91 20,390 1.02
Total 150,347 100.00 3,551 100.00 23,617 1.02
2014
Western
Tertiary Hospital 332 0.22 21 0.57 63,661 1.34
General Hospital 3,886 2.55 180 4.80 46,221 1.44
Hospital 11,366 7.47 372 9.96 32,755 1.05
Long-term care hospital 646 0.42 14 0.38 21,995 1.20
Clinic 75,535 49.66 1,868 49.94 24,725 1.00
Public Health Center 10 0.00 0 0.00 4,050 1.00
Local Public Health Clinic 14 0.01 0 0.00 8,487 3.43
Public Health Hospital 50 0.01 1 0.00 24,903 1.18
Dental Hospital 4 0.03 0 0.03 19,768 1.00
Total 91,843 60.39 2,456 65.69 26,745 1.03
Traditional
Traditional Hospital 892 0.59 20 0.55 22,893 1.08
Traditional Clinic 59,360 39.03 1,263 33.77 21,273 1.02
Total 60,252 39.61 1,283 34.31 21,297 1.02
Total 152,095 100.00 3,740 100.00 24,587 1.03
∗Patients with overlapping records were tallied as one patient (overlap was not allowed). †Costs determined to be eligible for reimbursement by the HIRA
(Health Insurance Review and Assessment Service) out of the total treatment amount were indicated in the submitted insurance claim statement. They are
expressed as means and are in Korean Won (1,000,000KRW). ‡Per diem is the average daily cost of services covered by National Health Insurance. §Days per
episode are the total number of outpatient visit days including drug prescription days divided by the total number of outpatient visits.
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Table 16: Number of hospitalizations for ankle and foot level lesions [S93] by hospital type.
Year Type ofmedicine Hospital type
Frequency Hospitalization costs LOS
𝑁
∗ % Cost† % Per diem‡ Days perepisode§
2011
Western
Tertiary Hospital 5 0.55 8 1.24 173,270 10.40
General Hospital 108 11.91 123 18.23 98,380 12.77
Hospital 345 38.04 280 41.41 84,468 10.59
Long-term care hospital 34 3.75 6 0.96 65,373 3.26
Western Clinic 368 40.57 241 35.54 56,559 12.45
Total 860 94.82 659 97.38 74,034 11.37
Traditional
Traditional Hospital 42 4.63 17 2.47 49,012 9.38
Traditional Clinic 5 0.55 1 0.15 34,441 6.80
Total 47 5.18 18 2.62 47,462 9.11
Total 907 100.00 677 100.00 72,657 11.25
2012
Western
Tertiary Hospital 10 0.99 12 1.61 193,439 6.00
General Hospital 148 14.70 156 20.70 108,791 11.49
Hospital 391 38.83 305 40.51 88,346 9.74
Long-term care hospital 38 3.77 12 1.61 82,398 5.34
Western Clinic 383 38.03 250 33.20 59,570 11.50
Total 970 96.33 734 97.63 80,954 10.49
Traditional
Traditional Hospital 32 3.18 16 2.17 46,740 12.50
Traditional Clinic 5 0.50 2 0.20 32,100 9.80
Total 37 3.67 18 2.37 44,761 12.14
Total 1,007 100.00 752 100.00 79,624 10.55
2013
Western
Tertiary Hospital 8 0.68 13 1.41 206,721 7.75
General Hospital 186 15.74 192 21.49 117,806 9.83
Hospital 465 39.34 390 43.78 104,115 8.94
Long-term care hospital 61 5.16 14 1.57 93,890 3.52
Western Clinic 398 33.67 262 29.42 64,569 11.39
Total 1,118 94.59 871 97.67 92,491 9.65
Traditional
Traditional Hospital 60 5.08 20 2.23 66,044 6.93
Traditional Clinic 4 0.34 1 0.11 22,968 11.50
Total 64 5.41 21 2.33 63,352 7.22
Total 1,182 100.00 891 100.00 90,913 9.52
2014
Western
Tertiary Hospital 9 0.66 10 0.92 200,250 6.00
General Hospital 214 15.65 234 22.08 127,396 10.31
Hospital 625 45.72 533 50.31 105,591 8.72
Long-term care hospital 72 5.27 24 2.27 92,879 5.67
Western Clinic 376 27.51 235 22.22 63,569 10.69
Total 1,296 94.81 1,036 97.81 96,951 9.36
Traditional
Traditional Hospital 61 4.46 20 1.90 58,725 7.28
Traditional Clinic 10 0.73 3 0.29 25,945 12.80
Total 71 5.19 23 2.19 54,108 8.06
Total 1,367 100.00 1,059 100.00 94,726 9.30
∗Patients with overlapping records were tallied as one patient (overlap not allowed). †Costs determined to be eligible for reimbursement by the HIRA (Health
Insurance Review and Assessment Service) out of the total treatment amount were indicated in the submitted insurance claim statement. They are expressed
as means and are in Korean Won (1,000,000KRW). ‡Per diem is the average daily cost of services covered by National Health Insurance. §Days per episode
are the total number of hospitalized days divided by the total number of hospitalizations.
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Table 17: Number of outpatient visits for ankle and foot level lesions [S93] by hospital type.
Year Type ofmedicine Hospital type
Frequency Outpatient costs LOS
𝑁
∗ % Cost† % Per diem‡ Days perepisode§
2011
Western
Tertiary Hospital 559 0.23 46 0.79 71,456 1.84
General Hospital 4,204 1.69 285 4.88 54,910 1.60
Hospital 10,466 4.22 571 9.77 35,586 1.69
Long-term care hospital 465 0.19 18 0.31 23,088 1.90
Clinic 107,340 43.28 2,471 42.30 23,025 1.00
Dental Hospital 6 0.00 0 0.01 16,350 2.67
Public Health Center 10 0.00 0 0.00 3,012 1.00
Local Public Health Clinic 18 0.01 0 0.00 7,036 2.56
Public Health Hospital 79 0.03 2 0.04 31,605 1.52
Total 123,147 49.65 3,395 58.10 25,402 1.09
Traditional
Traditional Hospital 1,141 0.46 45 0.78 18,915 2.03
Traditional Clinic 123,750 49.89 2,403 41.12 19,416 1.03
Total 124,891 50.35 2,448 41.90 19,412 1.04
Total 248,038 100.00 5,843 100.00 22,386 1.06
2012
Western
Tertiary Hospital 769 0.30 50 0.80 64,899 1.51
General Hospital 5,806 2.23 310 5.00 53,426 1.27
Hospital 17,632 6.76 625 10.07 35,457 1.06
Long-term care hospital 903 0.35 19 0.31 21,587 1.12
Clinic 107,284 41.16 2,589 41.71 24,132 1.00
Dental Hospital 31 0.01 1 0.01 26,883 1.00
Public Health Center 14 0.01 0 0.00 4,871 1.00
Local Public Health Clinic 23 0.01 0 0.00 9,318 4.30
Public Health Hospital 82 0.03 3 0.04 31,415 1.39
Total 132,544 50.85 3,597 57.96 27,142 1.03
Traditional
Traditional Hospital 2,414 0.93 54 0.86 22,190 1.06
Traditional Clinic 125,678 48.22 2,556 41.18 20,336 1.03
Total 128,092 49.15 2,609 42.04 20,371 1.03
Total 260,636 100.00 6,207 100.00 23,814 1.03
2013
Western
Tertiary Hospital 752 0.28 50 0.76 66,703 1.68
General Hospital 6,417 2.39 357 5.40 55,586 1.22
Hospital 18,960 7.05 675 10.22 35,603 1.05
Long-term care hospital 773 0.29 17 0.25 21,454 1.10
Clinic 109,956 40.91 2,731 41.35 24,835 1.00
Dental Hospital 4 0.00 0 0.00 25,545 1.00
Public Health Center 28 0.01 0 0.00 2,908 1.00
Local Public Health Clinic 23 0.01 0 0.00 6,697 2.83
Public Health Hospital 70 0.03 2 0.03 30,855 1.23
Total 136,983 50.96 3,832 58.02 27,972 1.02
Traditional
Traditional Hospital 2,255 0.84 52 0.79 23,228 1.05
Traditional Clinic 129,546 48.20 2,720 41.18 20,994 1.02
Total 131,801 49.04 2,772 41.98 21,032 1.02
Total 268,784 100.00 6,604 100.00 24,569 1.02
2014
Western
Tertiary Hospital 634 0.23 53 0.76 83,468 1.66
General Hospital 7,410 2.72 415 5.95 56,052 1.27
Hospital 19,690 7.24 715 10.25 36,321 1.05
Long-term care hospital 747 0.27 17 0.25 23,249 1.08
Clinic 111,528 41.01 2,884 41.34 25,857 1.00
Dental Hospital 3 0.00 0 0.00 19,330 1.00
Public Health Center 12 0.00 0 0.00 4,125 1.00
Local Public Health Clinic 16 0.01 0 0.00 10,259 4.63
Public Health Hospital 67 0.02 2 0.03 28,492 1.03
Total 140,107 51.52 4,087 58.58 29,169 1.03
Traditional
Traditional Hospital 2,080 0.76 51 0.73 24,517 1.04
Traditional Clinic 129,744 47.71 2,839 40.69 21,880 1.02
Total 131,824 48.48 2,890 41.42 21,922 1.02
Total 271,931 100.00 6,977 100.00 25,656 1.03
∗Patients with overlapping records were tallied as one patient (overlap not allowed). †Costs determined to be eligible for reimbursement by the HIRA (Health
Insurance Review and Assessment Service) out of the total treatment amount were indicated in the submitted insurance claim statement. They are expressed
as means and are in Korean Won (1,000,000KRW). ‡Per diem is the average daily cost of services covered by National Health Insurance. §Days per episode
are the total number of outpatient visit days including drug prescription days divided by the total number of outpatient visits.
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Table 18: Distribution of nonsurgical interventions in Western medicine and traditional Korean medicine.
Nonsurgical intervention Total Year 2011 2012 2013 2014
𝑁∗ 1,481,969 1,560,032 1,594,949 1,600,774
WM Basic physical therapy†
0 𝑁 947,982 1,000,863 1,034,024 1,033,566
% (63.97) (64.16) (64.83) (64.57)
1 𝑁 32,582 38,311 46,856 45,063
% (2.20) (2.46) (2.94) (2.82)
2 𝑁 136,773 137,871 126,126 122,500
% (9.23) (8.84) (7.91) (7.65)
3≦ N 364,632 382,987 387,943 399,645
% (24.60) (24.55) (24.32) (24.97)
WM Simple rehabilitation‡
0 𝑁 1,475,271 1,551,724 1,585,834 1,590,708
% (99.55) (99.47) (99.43) (99.37)
1≦ 𝑁 6,698 8,308 9,115 10,066
% (.45) (.53) (.57) (.63)
WM Professional rehabilitation§
0 𝑁 1,481,873 1,560,008 1,594,914 1,600,736
% (99.99) (100.00) (100.00) (100.00)
1≦ 𝑁 96 24 35 38
% (.01) (.00) (.00) (.00)
WM Rehabilitation of CNS
0 𝑁 1,481,962 1,560,029 1,594,942 1,600,773
% (100.00) (100.00) (100.00) (100.00)
1≦ 𝑁 7 3 7 1
% (.00) (.00) (.00) (.00)
TM Acupuncture
0 𝑁 982,471 1,062,109 1,085,224 1,102,972
% (66.29) (68.08) (68.04) (68.90)
1 𝑁 40,678 44,984 55,124 50,447
% (2.74) (2.88) (3.46) (3.15)
2≦ 𝑁 458,820 452,939 454,601 447,355
% (30.96) (29.03) (28.50) (27.95)
TM Moxibustion
0 𝑁 1,481,922 1,559,985 1,594,876 1,600,667
% (100.00) (100.00) (100.00) (99.99)
1≦ 𝑁 47 47 73 107
% (.00) (.00) (.00) (.01)
TM Cupping
0 𝑁 1,481,712 1,559,844 1,594,897 1,600,518
% (99.98) (99.99) (100.00) (99.98)
1≦ 𝑁 257 188 52 256
% (.02) (.01) (.00) (.02)
TM Heat & cold therapy
0 𝑁 1,481,856 1,559,985 1,594,897 1,600,734
% (99.99) (100.00) (100.00) (100.00)
1≦ 𝑁 113 47 52 40
% (.01) (.00) (.00) (.00)
∗A patient could be hospitalized more than once during the study period, resulting in more than one claim per patient. Thus, the number of claims in
the study was higher than the number of patients. †Basic physical therapy included superficial heat therapy, cold therapy, deep heat therapy, ultraviolet
irradiation, transcutaneous electrical nerve stimulation, massage therapy, and simple therapeutic exercise. ‡Simple rehabilitation included paraffin bath,
hydrotherapy, intermittent traction therapy, electrical stimulation therapy, laser therapy, therapeutic exercise, motor point block, pneumatic compression,
complex decongestive physical therapy, and iontophoresis. §Professional rehabilitation included pool therapy, occupational therapy, activities of daily living
training, neurogenic bladder training, functional electrical stimulation therapy, myofascial trigger point injection, rehabilitative social work, rehabilitative
breathing therapy, rehabilitative functional training, and rehabilitative dysphagia therapy. WM, Western medicine; TM, traditional Korean medicine.
Despite the high demand for traditional Koreanmedicine
for musculoskeletal diseases, traditional Korean medical
practitioners are precluded from diagnosing joint disorders
independently due to regulatory restrictions in imaging
device use. We confirmed this fact again by comparing
subgroup costs related to the type of medicine in total
treatment cost. Apart from procedures such as acupuncture,
moxibustion, and cupping, many treatments were not cov-
ered by the NHI (Table 7). Large variations in diagnostic
and therapeutic management between Western medicine
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and traditional Korean medicine indicate that more items
in Korean medicine need to be covered and developed.
Among the hospitalized patients, the number of claims for all
years after 2011 increased mostly for shoulder joints (78.43%)
compared to 2011, followed by knees (61.93%), foot (50.72%),
and hands (16.29%). While the rate of use of traditional
Korean medicine for the shoulder region slightly decreased
in outpatient care, the number of hospitalizations increased
sharply (Table 9). It is interesting that the proportion of tradi-
tional hospitalization increase for the knee and shoulder
regions (shoulder: 105.00%, knee: 250.00%) was higher than
that of Western medicine clinic hospitalization (shoulder:
77.99%, knee: 58.04%). In Korea, the medical delivery system
of traditional medicine is not strict. Individuals can choose
to visit primary medical institutions (Traditional Clinic) and
higher medical institutions (Traditional Hospital). Shoulder
and knee joint diseases are common musculoskeletal dis-
eases.They are usually treated in primary care settings. How-
ever, if there is no response or a lack of effectiveness in
primary care, a Traditional Hospital is attended for a more
accurate diagnosis and evaluation. This might be the reason
why there is increase in hospitalization in Traditional Hospi-
tals that hire orthodox medical practitioners who can use X-
rays and magnetic resonance imaging. Besides, because tra-
ditional medical practitioners cannot use these examination
devices in a Traditional Clinic, outpatient care in Traditional
Clinics was much lower compared to that inWestern Clinics.
Although simple radiology is helpful in the diagnosis of
joint disease [28], patient might suffer the inconvenience of
going to both Western and Traditional Clinics for accurate
diagnosis due to legal restrictions [29].
Traditional Korean medicine had lower medical expen-
ditures than Western medicine (inpatient care cost: Western
medicine clinic, 160,000KRW; traditional Korean medicine
clinic, 50,000KRW; outpatient care cost: Western medicine,
22,000KRW; traditional Koreanmedicine, 18,000KRW).The
average treatment cost for traditional Korean medicine was
lower compared to that for Western medicine. RPE ranged
from 181,225 KRW to 198,661 KRW forWesternmedicine and
82,019 KRW to 96,325KRW for traditional Korean medicine.
In addition, out-of-pocket expenses for Western medicine
(44,240KRW to 49,621 KRW) were higher than those of
traditional Korean medicine (20,154KRW to 22966KRW).
Although expenditures for traditional Korean medicine were
significantly lower compared to those for Western medicine,
daily cost amount showed no significant difference between
the two depending on the year. These results are similar to
those of a previous study [6].
Most patients had mild joint diseases (more than 70%)
with CCI scores of 0 and underwent nonsurgical treatment.
Regardless of disease type, the proportion of surgery was less
than 1%. Therefore, traditional medical care can serve as
an alternative to Western medical care. We found that the
proportion of acupuncture was slightly higher than basic
physical therapy (Table 18). However, further research is
needed to confirm that traditional Korean medicine is cost-
effective for managing joint diseases.
This study has several limitations. First, the study was
descriptive in nature. It reported sociodemographic charac-
teristics, procedures, medication, and average cost for treat-
ing joint disorders without addressing a specific hypothesis.
Recently, research results have been utilized as basis for
policies by utilizing health-related big data. However, there is
a lack of data analyzing various patterns of traditionalmedical
services [30]. Although there are studies that use NHI claims
data, they are limited to a single year or disease range [8, 13].
This study is novel in that it compared the utilization ofWest-
ern medicine and traditional Korean medicine for the treat-
ment of joint disorders in Korea. We believe the current
study would serve as a good reference for countries with
similar medical systems as that of Korea and would be able to
contribute to international literature. Further research is
required, such as analysis of factors influencing the use or
frequency of Korean traditional medicine using multivariate
statistics.
Second, while fee-for-service for nationally covered
health care service was comprehensively recorded in the
claim database, nonreimbursable items such as traditional
drugs did not generate billing data. In addition, we only
calculated direct medical costs based on information in
the claim database. In general, there are nonmedical costs
such as transportation costs and lost productivity due to
morbidity because joint diseases tend to be chronic. In addi-
tion, the costs did not uncover items based on claims data
that only contained information about medical services pro-
vided under the NHI. If uncovered items were included, the
costs for traditional Korean medicine might be higher than
that ofWestern medicine. In a previous study [31] comparing
Western and traditional Korean medicine users, it was found
that the traditional Korean medicine user group paid signif-
icantly more medical expenses than the Western medicine
user group. In a study on the determinants of traditional
Koreanmedicine use based on panel data [32], the number of
patients using traditional Korean medicine was significantly
higher than those using Western medicine. This is because
the insurance benefit for traditional Koreanmedicine is lower
than that for Western medicine.
Third, we did not include essential factors influencing
choice of medical practice, such as education level, income,
residence, severity, and health-related risk factors (e.g., alco-
hol consumption, smoking, and exercise) [33]. Previous
studies have shown that factors affecting the use of traditional
Korean medicine are not related to education level or income
level [34, 35], high education level [14], low education level
[36, 37], and low or high-income level [32]. In previous
studies, factors such as the use of a therapist [33], confidence
in orientalmedical institution [32], recognition of therapeutic
effect [38], and coping attitude of the oriental medical treat-
ment [39] have been found to be significant factors. Although
these essential variables are important parameters in choos-
ing hospitals, they weremissed due to the nature of the claims
data. To overcome the omission of disturbance variables,
medical insurance type (NHI orMedicaid) and region of hos-
pital were used as surrogates of income and residence in this
study. In addition, we considered disease severity by using
CCI because severity of disease might greatly affect hospital
choice. The remaining factors have been judged due to
their impacts on health care utilization. We believe that the
direction of the analysis of this study will not change. Due
to the limitation in data characteristics, these elements were
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not included in this study. Future studies considering these
factors are needed to confirm our findings.
Finally, the accuracy of diagnoses has been an issue due
to the nature of claims data collected with the purpose of
reimbursing health care services and not for clinical purposes
[18]. The accuracy of diagnosis in the KNHI claims data has
been reported to be about 70% [40]. Moreover, the accuracy
of disease classification has been reported to be higher
for inpatients than for outpatients. It is higher for severe
disorders than for common mild disorders. It is also higher
in General Hospitals than in clinics [41]. Nonetheless, in the
process of designing this study, physicians in current practice
concurred that these codes were not clearly differentiated
for diagnosis in actual clinical practice settings in Korea.
Therefore, analysis was performed in primary and secondary
diagnoses in accordance with the opinion that various issues
should be taken into account (e.g., private insurance, medical
care institution characteristics, and individual differences in
physicians) in category division. In addition, primary and
secondary diagnoses are generally used in conjunction [14].
Therefore, in definingmedical care usage due to joint disease,
we reviewed not only the major diagnosis code, but also
secondary diagnosis code. Despite our efforts, the diagnosis
accuracy for joint diseases in this study might be challenged.
Despite these limitations, our study has several strengths.
First, we analyzed age-stratified and gender-stratified ran-
dom samples of the KNHI claims database representing
98% of the South Korean population. Claims statements
covered extensive information on health care interventions
(e.g., treatment, procedures, diagnostic tests, and prescrip-
tion drugs), diagnosis, NHI payment cost, beneficiaries’
out-of-pocket expenses, sociodemographic characteristics,
and medical institutions, thus providing useful nationwide
epidemiological data. Its representativeness, reliability, and
validity have been confirmed previously [41]. However, there
is a lack of data necessary to understand various consumption
patterns and supply patterns of traditional medical services
[30].
Second, there are studies in other countries that analyze
the status of traditional Korean medicine utilization by using
representative data source [30, 42–44]. Unlike most previous
clinical studies whose duration was less than one year, we
attempted to analyze the change over four years for joint
diseases based on the type of medicine used (Western or
traditional Korean medicine). Until now, no studies have
reported national data on the management of joint disorders
for 2011 to 2014. This study holds significance in that it is
the first study that reports distinct differences in patterns of
medical care use and costs between Western medicine and
traditional Korean medicine.
An added strength of this study was that it provided
patterns of complementary and alternative medicine treat-
ment for joint disorders in Korea by covering traditional
Korean medicine treatments as acupuncture, moxibustion,
and cupping in the NHI.
Third, we constructed pilot medical episode data consid-
ering characteristics of health claim data for joint diseases.
This can be used as a data processing technique to calculate
basic dynamics information. Health insurance claim data
were produced by physicians based on diagnosis at the first
visit to the hospital. Related claim data were then produced,
including the diagnosis code, the date of initiation of treat-
ment (hospitalization or outpatient), and personal informa-
tion (age, sex). To use epidemiological data, it is necessary
to link the billing statement classified for administrative pur-
poses to the same hospitalization case [45]. In this study, the
same patient filed a billing statement with the same hospital
in the same medical institution for inpatient care. The date
was connected to one hospitalization case.
Our study has several policy implications. As disease
structure can change from acute to chronic degenerative dis-
ease, interest in traditional medicine is increasing with aging.
Themain purpose of traditional medicine use in South Korea
is to prevent disease and promote general health [10].Though
traditional medicine plays a substantial role in the Korean
health care system, the annual number of health insurance
claims from traditional Korean medicine institutions has
stagnated and decreased since 2012 [46]. Medical use is
affected by demographic, socioeconomic, and psychocultural
factors. It has been reported that these factors can affect
health care utilization by interactions between factors rather
than independent factors [47, 48]. Therefore, it is important
to grasp the current position of traditional Korean medicine
in order to prepare policy and directives. Currently, difference
in standards of practice underlies mistrust for traditional
Korean medicine among Western medical practitioners [6].
To overcome conflicts among orthodox and traditional prac-
titioners, we need an effective health care delivery system that
encourages consultation for both Western and traditional
Korean medicine with accessibility. Further discussion must
be considered by providing consultation programs for other
chronic diseases and joint diseases.
5. Conclusions
This study provided objective information about epidemio-
logic characteristics of patients with joint disorders treated
with Western medicine and traditional Korean medicine.
It provided an understanding about the recent status and
trends. It will provide a basis for further expansion of tradi-
tional Korean medicine for patients with muscular disorders.
Based on HIRA data, medical use for joint disorders showed
significant difference between the groups. It provides basic
information for future usual care guidelines linked to health
policy and budget appropriation. Timely and accurate infor-
mation is essential for policy-makers to make decisions. The
results of our study will contribute to management decisions
for musculoskeletal diseases involving joint disorders.
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